PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 15, 1992Biochemical Journal78 citationsOpen Access

Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment

DKDavid J. KingJAJohn R. AdairSASarojani Angal

Key Points

Key points are not available for this paper at this time.

Abstract

B72.3 is a mouse monoclonal antibody against a tumour-associated antigen, TAG72, which recognizes breast, ovarian and colorectal tumour tissue. A mouse-human chimeric version of B72.3 has been expressed in Chinese-hamster ovary cells. This molecule has the binding specificity of B72.3 and constant regions from human IgG4. The chimeric B72.3 assembles to intact IgG and recognizes TAG72 as well as B72.3 in competitive binding assays. A proportion of the chimeric B72.3 (approx. 10%) does not form inter-heavy-chain disulphide bonds but still assembles into the IgG tetramer. This appears to be a general property of human IgG4 molecules. Co-expression of the chimeric light chain with a chimeric Fd' gene resulted in the expression of functional Fab'. Very little F(ab')2 is produced, although the Fab' can be oxidized to the dimeric F(ab')2 in vitro. The production of Fab' and F(ab')2 by this method is an attractive alternative to proteolytic digestion of IgG. The ability to produce these molecules in large quantities will allow the production and testing of a range of anti-tumour antibody and antibody fragment conjugates.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

King et al. (1992) studied this question.

synapsesocial.com/papers/6a8141aa0914b5fb8de3f09ehttps://doi.org/10.1042/bj2810317
Ask AI
Helpful
Bookmark
Share
View Full Paper